Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of drugmaker KV Pharmaceutical (NYSE: KV-A ) climbed 13% in intraday trading Wednesday on fairly typical volume.
So what: KV was one of last week's biggest losers after receiving political scrutiny for jacking up the price of its preventive preterm birth treatment, Makena, so a big double-digit bounce shouldn't come as a huge surprise. With a beta of three and so much controversy surrounding KV's alleged price gouging tactics, the stock is rapidly becoming an active trader's dream situation.
Now what: KV shares aren't for the faint of heart. While Makena's whopping profit potential has fueled the stock to great heights, it's tough not to notice the ever-increasing outrage toward KV from patients, doctors, and now politicians. As the situation plays itself out and sentiment sways back and forth, investors can expect plenty more opportunities -- be it long or short -- to arise.
Interested in more info on KV? Add it to your watchlist.